Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Sarcoma 192Osteosarcoma 72Sarcoma, Ewing 49Rhabdomyosarcoma 44Melanoma 40Neuroblastoma 35Gastrointestinal Stromal Tumors 34Neoplasms 32Colorectal Neoplasms 29Glioblastoma 28Bone Neoplasms 27Neoplasm Metastasis 26Ovarian Neoplasms 25Breast Neoplasms 25Wilms Tumor 22Gliosarcoma 22Glioma 22Rhabdoid Tumor 21Lymphoma, Non-Hodgkin 21Sarcoma, Kaposi 20Liposarcoma 20Carcinoma, Non-Small-Cell Lung 20Pancreatic Neoplasms 18Neurofibrosarcoma 18Medulloblastoma 18Hepatoblastoma 18Carcinoma, Renal Cell 18Lymphoma 17Leiomyosarcoma 17Desmoid Tumors 17

Interventions

fludarabine 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Gaucher Disease × Sarcoma × 90 days × Clear all
NCT03721068 2026-03-27

Study of CAR T-Cells Targeting the GD2 With IL-15+iCaspase9 for Relapsed/Refractory Neuroblastoma or Relapsed/Refractory Osteosarcoma

UNC Lineberger Comprehensive Cancer Center

Phase 1 Recruiting
18 enrolled
CNSSarcoma

Gaucher Disease, Neuroblastoma, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡